Healthcare Technology
GE HealthCare Secures CE Mark for MINItrace Magni
Medical Device Network reports GE HealthCare secured CE Mark certification for MINItrace Magni and broadened Copper-64 manufacturing.

GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron, according to Medical Device Network. The publisher also reported that GE HealthCare broadened its PETtrace Solid Target Platform to manufacture Copper-64.
The update combines a reported certification milestone for the MINItrace Magni cyclotron with an expansion of manufacturing capability on the PETtrace Solid Target Platform. Medical Device Network identified both developments in its report on GE HealthCare.
CE Mark reported for MINItrace Magni
Medical Device Network reported that GE HealthCare secured CE Mark certification for the MINItrace Magni cyclotron. The reported CE Mark applies to the MINItrace Magni product named in the announcement.
For medical and veterinary sales professionals following imaging and nuclear medicine technology, the announcement provides a product-specific regulatory update from GE HealthCare. Discussions of the development can distinguish the reported CE Mark certification for MINItrace Magni from the separate manufacturing update involving the PETtrace Solid Target Platform.
PETtrace platform broadened for Copper-64
In the same report, Medical Device Network said GE HealthCare broadened its PETtrace Solid Target Platform to manufacture Copper-64. The publisher presented the Copper-64 manufacturing capability alongside the MINItrace Magni CE Mark certification.
The two reported items concern different GE HealthCare offerings: the MINItrace Magni cyclotron and the PETtrace Solid Target Platform. Together, they form the core of Medical Device Network’s update on the company’s cyclotron and manufacturing technology activity.
Reported developments
- GE HealthCare secured CE Mark certification for its MINItrace Magni cyclotron.
- GE HealthCare broadened its PETtrace Solid Target Platform to manufacture Copper-64.
- Medical Device Network reported both developments.
Medical Device Network did not provide further details in the supplied report summary on the scope of the CE Mark certification or the expanded Copper-64 manufacturing capability. The available update identifies the certification, the MINItrace Magni cyclotron, the PETtrace Solid Target Platform, and Copper-64 as the reported elements of the announcement.
Sources
- Medical Device Network — Oct 16, 2026



